drugset / Trial / NCT03475459

Investigation of Arrhythmogenic Effect of NPC-15 (NPC-15-7)

NCT03475459

Phase 1 Completed 12 enrolled Nobelpharma
NaSingle-groupOpen-labelTreatment

Summary

A study to assess the QTc prolongation effect of NPC-15 (melatonin 8mg or 16mg)

Timeline

Start
2018-04-03
Primary completion
2018-04-29
Completion
2018-04-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 4 g Oral
Subject Melatonin Small molecule 8 g Oral

Indications